Caplin Point Laboratories informs about press release

16 Apr 2024 Evaluate

Caplin Point Laboratories has informed that it enclosed press release regarding grant of final approval from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Ofloxacin Ophthalmic Solution 0.3% (eye drops), to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1303.05 -28.05 (-2.11%)
03-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.